MARAMAI, SAMUELE
 Distribuzione geografica
Continente #
EU - Europa 3.143
NA - Nord America 3.000
AS - Asia 1.898
SA - Sud America 310
AF - Africa 92
OC - Oceania 3
Totale 8.446
Nazione #
US - Stati Uniti d'America 2.928
IT - Italia 813
RU - Federazione Russa 654
CN - Cina 558
SG - Singapore 539
GB - Regno Unito 521
IE - Irlanda 264
BR - Brasile 243
DE - Germania 240
VN - Vietnam 215
HK - Hong Kong 158
SE - Svezia 136
FR - Francia 135
FI - Finlandia 130
KR - Corea 116
UA - Ucraina 98
IN - India 91
BD - Bangladesh 63
ZA - Sudafrica 48
TR - Turchia 37
CA - Canada 35
ES - Italia 31
AR - Argentina 28
JP - Giappone 25
MX - Messico 24
NL - Olanda 23
AT - Austria 21
PL - Polonia 18
IQ - Iraq 16
EC - Ecuador 15
ID - Indonesia 13
PK - Pakistan 13
BE - Belgio 10
CZ - Repubblica Ceca 10
EG - Egitto 10
NG - Nigeria 9
CO - Colombia 8
JO - Giordania 7
CI - Costa d'Avorio 6
IR - Iran 6
SA - Arabia Saudita 6
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
CL - Cile 4
HU - Ungheria 4
IL - Israele 4
MA - Marocco 4
NP - Nepal 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EE - Estonia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
GY - Guiana 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
Totale 8.440
Città #
Dallas 539
Southend 435
Singapore 338
Dublin 261
Fairfield 213
Ashburn 210
Siena 202
San Jose 170
Moscow 164
Hefei 161
Chandler 150
Hong Kong 148
Santa Clara 144
Milan 121
Munich 121
Seoul 114
Beijing 103
Woodbridge 97
Wilmington 91
Helsinki 90
Seattle 90
Florence 88
Ann Arbor 81
Houston 80
Los Angeles 78
Jacksonville 74
Cambridge 68
New York 65
Hanoi 61
Ho Chi Minh City 54
The Dalles 45
Council Bluffs 44
Johannesburg 44
Lauterbourg 39
Bengaluru 35
Princeton 33
Rome 30
Shanghai 30
Nanjing 27
Izmir 26
Dearborn 25
Boardman 23
Tokyo 23
São Paulo 20
Buffalo 19
San Diego 18
London 16
Frankfurt am Main 15
Orem 15
Vienna 15
Amsterdam 14
Da Nang 13
Lappeenranta 13
Warsaw 13
Bari 12
Chicago 12
Columbus 12
Fremont 12
Nuremberg 12
Rio de Janeiro 12
Redondo Beach 11
Toronto 11
Washington 11
Chennai 10
Düsseldorf 10
Guangzhou 10
Haiphong 10
Naples 10
Parma 10
San Mateo 10
Turku 10
Abuja 9
Bologna 9
Brooklyn 9
Brussels 9
L’Aquila 9
Mexico City 9
Mogliano 9
Salt Lake City 9
Brno 8
Guayaquil 8
Palermo 8
San Francisco 8
Aligarh 7
Boston 7
Cairo 7
Lancaster 7
Montreal 7
Málaga 7
Nanchang 7
Phoenix 7
Stockholm 7
Turin 7
Abidjan 6
Amman 6
Baghdad 6
Belo Horizonte 6
Changsha 6
Charlotte 6
Jakarta 6
Totale 5.607
Nome #
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 438
Development of novel cyclic peptides as pro-apoptotic agents 388
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 379
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 328
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 328
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 314
A stereoselective approach to peptidomimetic BACE1 inhibitors 292
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 276
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 273
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 270
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 265
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 236
Disease modifying anti-Alzheimer’s drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation 232
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 214
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 214
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 213
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition 212
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 207
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 204
An Intramolecular Hydroaminomethylation-Based Approach to Pyrrolizidine Alkaloids under Microwave-Assisted Heating 201
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 195
Catechol-O-methyltransferase (COMT) 195
Exploiting the bile acid binding protein as transporter of a Cholic Acid/Mirin bioconjugate for potential applications in liver cancer therapy 193
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization 184
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies 179
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening 171
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 159
Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors 158
Micellar catalysis for sustainable hydroformylation 158
Development of a practical and scalable route for the preparation of the deacetoxytubuvaline (dTuv) fragment of pretubulysin and analogs 153
Structural characterization of human heat shock protein 90 N-Terminal domain and its variants K112R and K112A in complex with a potent 1,2,3-Triazole-based inhibitor 148
CHAPTER 18: Microwave Irradiation 145
Subtype selective γ-Aminobutyric scid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: an update 144
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 143
Macroreticular POLITAG-Pd(0) for the waste minimized hydrogenation/reductive amination of phenols using formic acid as hydrogen source 122
null 109
Inhibition of monoacylglycerol lipase by NSD1819 as an effective strategy for the endocannabinoid system modulation against neuroinflammation-related disorders 96
Multitarget therapeutic strategies for Alzheimer's disease: review on emerging target combinations 88
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation 82
Therapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment 71
Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage? 67
Targeting endocannabinoid metabolism: an arrow with multiple tips against multiple sclerosis 55
Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH-SY5Y-Derived Neurons 55
Drug enteric metabolism in gut microbiota-brain crosstalk 50
Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain 5
Totale 8.609
Categoria #
all - tutte 23.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 0 20
2021/2022439 39 48 44 45 16 15 31 21 20 45 48 67
2022/2023587 23 43 74 72 72 122 28 54 62 18 12 7
2023/2024670 50 24 70 42 49 135 150 10 11 23 22 84
2024/20251.560 61 51 149 95 140 98 130 103 142 86 134 371
2025/20263.682 299 520 463 490 615 145 456 143 148 208 121 74
Totale 8.609